Certificate of Analysis
Each batch of AOD-9604 undergoes rigorous third-party testing to ensure purity and identity verification. The lab report for the latest batch is being finalized.
AOD-9604
Anti-Obesity Drug 9604 is a modified fragment of human growth hormone (HGH fragment 177-191). This peptide is researched for its effects on lipid metabolism in laboratory settings.
99%+
10mg
Bundle & Save
Order before 2 PM EST, ships the same day. Fast, fully tracked, and sent in discreet, secure packaging. Free shipping on orders over $99.
Purity Guarantee. If independent third-party testing doesn't confirm our stated purity standards, you get a full refund plus a free replacement.
For Research Use Only
Intended for in-vitro research only. Not for human consumption. Must be 21+.
Specifications
Certificate of Analysis
Each batch of AOD-9604 undergoes rigorous third-party testing to ensure purity and identity verification. The lab report for the latest batch is being finalized.
Overview
Biochemical Characteristics
AOD-9604 represents the C-terminal fragment of human growth hormone with an added N-terminal tyrosine. The disulfide bond between the two cysteine residues maintains structural integrity and biological activity in experimental models.
Research Applications
Pathway / Mechanistic Context
Preclinical Research Summary
Form & Analytical Testing
Mechanisms of Action
Lipolytic Activation - Stimulates adipocyte triglyceride hydrolysis through hormone-sensitive lipase
Beta-3 Adrenergic Modulation - Interacts with β3-adrenergic receptor signaling pathways
IGF-1 Independent - Does not elevate insulin-like growth factor-1 levels unlike full-length GH
Glucose Neutral Profile - No significant effects on blood glucose homeostasis or insulin sensitivity
Research Applications
1Lipid Metabolism Research
Studies on fat metabolism and adipose tissue biology.
Key Research Findings
- Stimulates lipolysis in adipocytes through HSL activation
- Reduces lipogenesis and fat accumulation in research models
- Did not induce hyperglycemia or insulin resistance in animal studies
- Did not raise IGF-1 levels in published studies, unlike full-length GH
2Adipocyte Biology
Research on adipocyte function and differentiation.
Key Research Findings
- Modulates adipocyte lipid storage and release
- Affects preadipocyte differentiation pathways
- Influences adipokine secretion patterns
- Selective effects on white adipose tissue
3Metabolic Signaling Studies
Investigation of metabolic pathways and signaling cascades.
Key Research Findings
- Activates β3-adrenergic signaling pathways
- Increases cAMP and PKA activity in adipocytes
- Does not activate growth hormone receptor
- Useful for studying GH fragment structure-activity
Supporting Research & Bibliography
The following peer-reviewed publications support the research applications described above. References are provided for informational purposes to assist researchers in their literature review.
Safety and tolerability of the hexadecapeptide AOD9604 in humans
Stier H, Vos E, Kenley D.
Total references: 4
Note: The information provided is for research reference only. It summarizes published in-vitro, animal and, where cited, human clinical studies of the compound; findings from those studies are not claims about this product. This product is intended for laboratory research purposes only. Not for human or veterinary use.
Research Use Only: This product is intended for laboratory research purposes only. Not for human or veterinary use. By purchasing, you confirm that you are a qualified researcher and will use this product in accordance with all applicable regulations.